CureVac To Receive Up To EUR 252 Euros For Further Covid-19 Vaccine Development

T-Reuters2020-09-04

CureVac NV :Curevac Expected To Receive Up To 252 Million Euros From German Federal Ministry Of Research For Further Covid-19 Vaccine Development And Production Capacity Expansion.Ministry Submits Official Notification Of Funding To Curevac.Grant As Part Of Special Program To Accelerate Covid-19 Vaccine Development Tübingen, Germany / Boston, Usa -.Curevac Expects Funding Of Up To 103 Million Euros In 2020 And Up To 149 Million Euros In 2021.Grant Is Expected To Be Used For Rapid Expansion Of Vaccine Production.

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

jasonhcs
2020-09-05
jasonhcs
252欧是真牛
- 特斯拉123456:
  2.52亿
- 特斯拉123456:
  252亿

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2064966602?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2020-09-04 21:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2064966602","market":"us","top_or_hot":-1,"title":"CureVac To Receive Up To EUR 252 Euros For Further Covid-19 Vaccine Development","media":"T-Reuters","content":"<html><body><p>CureVac NV <cvac.o>:Curevac Expected To Receive Up To 252 Million Euros From German Federal Ministry Of Research For Further Covid-19 Vaccine Development And Production Capacity Expansion.Ministry Submits Official Notification Of Funding To Curevac.Grant As Part Of Special Program To Accelerate Covid-19 Vaccine Development Tübingen, Germany / Boston, Usa -.Curevac Expects Funding Of Up To 103 Million Euros In 2020 And Up To 149 Million Euros In 2021.Grant Is Expected To Be Used For Rapid Expansion Of Vaccine Production.</cvac.o></p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CureVac To Receive Up To EUR 252 Euros For Further Covid-19 Vaccine Development</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCureVac To Receive Up To EUR 252 Euros For Further Covid-19 Vaccine Development\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086160438\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">T-Reuters </p>\n<p class=\"h-time\">2020-09-04 21:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>CureVac NV <cvac.o>:Curevac Expected To Receive Up To 252 Million Euros From German Federal Ministry Of Research For Further Covid-19 Vaccine Development And Production Capacity Expansion.Ministry Submits Official Notification Of Funding To Curevac.Grant As Part Of Special Program To Accelerate Covid-19 Vaccine Development Tübingen, Germany / Boston, Usa -.Curevac Expects Funding Of Up To 103 Million Euros In 2020 And Up To 149 Million Euros In 2021.Grant Is Expected To Be Used For Rapid Expansion Of Vaccine Production.</cvac.o></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CVAC","symbol_name":"CureVac B.V.","start_time":0,"source_url":"https://www.trkd.thomsonreuters.com","article_id":"2064966602","we_media_id":"1086160438","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2064966602","pubTimestamp":1599224712,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"T-Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1086160438","head_image":"https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5"},"summary":"CureVac NV :Curevac Expected To Receive Up To 252 Million Euros From German Federal Ministry Of Rese","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CVAC":"CureVac B.V."},"translate_title":"CureVac将获得高达252欧元的资金，用于进一步开发Covid-19疫苗","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CVAC":0.9},"content_text":"CureVac NV :Curevac Expected To Receive Up To 252 Million Euros From German Federal Ministry Of Research For Further Covid-19 Vaccine Development And Production Capacity Expansion.Ministry Submits Official Notification Of Funding To Curevac.Grant As Part Of Special Program To Accelerate Covid-19 Vaccine Development Tübingen, Germany / Boston, Usa -.Curevac Expects Funding Of Up To 103 Million Euros In 2020 And Up To 149 Million Euros In 2021.Grant Is Expected To Be Used For Rapid Expansion Of Vaccine Production.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[{"id":978509546,"gmtCreate":1599243086185,"gmtModify":1703818243597,"author":{"id":"3452317408091005","authorId":"3452317408091005","name":"jasonhcs","avatar":"https://static.tigerbbs.com/5dd9073e25fe5709f8c6120b10625a27","vip":1,"hat":"https://static.tigerbbs.com/75944ad144f2566ba526ce9b292d3cd2","crmLevel":2,"crmLevelSwitch":0,"idStr":"3452317408091005","authorIdStr":"3452317408091005"},"htmlText":"252欧是真牛","listText":"252欧是真牛","text":"252欧是真牛","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/978509546","repostId":2064966602,"repostType":2,"repost":{"id":"2064966602","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"T-Reuters","id":"1086160438","head_image":"https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5"},"pubTimestamp":1599224712,"share":"https://www.laohu8.com/m/news/2064966602?lang=&edition=full","pubTime":"2020-09-04 21:05","market":"us","language":"en","title":"CureVac To Receive Up To EUR 252 Euros For Further Covid-19 Vaccine Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2064966602","media":"T-Reuters","summary":"CureVac NV :Curevac Expected To Receive Up To 252 Million Euros From German Federal Ministry Of Rese","content":"<html><body><p>CureVac NV <cvac.o>:Curevac Expected To Receive Up To 252 Million Euros From German Federal Ministry Of Research For Further Covid-19 Vaccine Development And Production Capacity Expansion.Ministry Submits Official Notification Of Funding To Curevac.Grant As Part Of Special Program To Accelerate Covid-19 Vaccine Development Tübingen, Germany / Boston, Usa -.Curevac Expects Funding Of Up To 103 Million Euros In 2020 And Up To 149 Million Euros In 2021.Grant Is Expected To Be Used For Rapid Expansion Of Vaccine Production.</cvac.o></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CureVac To Receive Up To EUR 252 Euros For Further Covid-19 Vaccine Development</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCureVac To Receive Up To EUR 252 Euros For Further Covid-19 Vaccine Development\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086160438\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">T-Reuters </p>\n<p class=\"h-time\">2020-09-04 21:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>CureVac NV <cvac.o>:Curevac Expected To Receive Up To 252 Million Euros From German Federal Ministry Of Research For Further Covid-19 Vaccine Development And Production Capacity Expansion.Ministry Submits Official Notification Of Funding To Curevac.Grant As Part Of Special Program To Accelerate Covid-19 Vaccine Development Tübingen, Germany / Boston, Usa -.Curevac Expects Funding Of Up To 103 Million Euros In 2020 And Up To 149 Million Euros In 2021.Grant Is Expected To Be Used For Rapid Expansion Of Vaccine Production.</cvac.o></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CVAC":"CureVac B.V."},"source_url":"https://www.trkd.thomsonreuters.com","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2064966602","content_text":"CureVac NV :Curevac Expected To Receive Up To 252 Million Euros From German Federal Ministry Of Research For Further Covid-19 Vaccine Development And Production Capacity Expansion.Ministry Submits Official Notification Of Funding To Curevac.Grant As Part Of Special Program To Accelerate Covid-19 Vaccine Development Tübingen, Germany / Boston, Usa -.Curevac Expects Funding Of Up To 103 Million Euros In 2020 And Up To 149 Million Euros In 2021.Grant Is Expected To Be Used For Rapid Expansion Of Vaccine Production.","news_type":1,"symbols_score_info":{"CVAC":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":2855797,"gmtCreate":1600091516530,"gmtModify":1600091516530,"authorId":3560760130552264,"author":{"id":3560760130552264,"idStr":"3560760130552264","authorId":3560760130552264,"name":"特斯拉123456","avatar":"https://static.tigerbbs.com/9829f6338f74ebe9686349fc8f580ae3","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":978509546,"type":1,"supId":2855793,"prevId":0,"content":"2.52亿","text":"2.52亿","html":"2.52亿"},{"id":2855793,"gmtCreate":1600091488674,"gmtModify":1600091488674,"authorId":3560760130552264,"author":{"id":3560760130552264,"idStr":"3560760130552264","authorId":3560760130552264,"name":"特斯拉123456","avatar":"https://static.tigerbbs.com/9829f6338f74ebe9686349fc8f580ae3","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":978509546,"type":1,"supId":0,"prevId":0,"content":"252亿","text":"252亿","html":"252亿"}],"langContent":"CN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":0,"commentSize":1,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.9","shortVersion":"4.34.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2064966602","isCrawlerRequest":true}